TDX105
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TDX105, covering 2022-03-21 to 2022-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105 [Phase 2]